Home/Filings/4/0000905148-24-002584
4//SEC Filing

Leone John 4

Accession 0000905148-24-002584

CIK 0001720420other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 6:45 PM ET

Size

16.4 KB

Accession

0000905148-24-002584

Insider Transaction Report

Form 4
Period: 2024-09-23
Transactions
  • Sale

    Common Shares

    2024-09-24$19.82/sh20,000$396,4621,884,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-25$19.89/sh20,000$397,7441,864,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-23$20.00/sh20,000$400,0361,904,739 total(indirect: See Footnotes)
Leone John
Director10% Owner
Transactions
  • Sale

    Common Shares

    2024-09-24$19.82/sh20,000$396,4621,884,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-23$20.00/sh20,000$400,0361,904,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-25$19.89/sh20,000$397,7441,864,739 total(indirect: See Footnotes)
Clowe Kevin
10% Owner
Transactions
  • Sale

    Common Shares

    2024-09-24$19.82/sh20,000$396,4621,884,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-23$20.00/sh20,000$400,0361,904,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-25$19.89/sh20,000$397,7441,864,739 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Shares

    2024-09-23$20.00/sh20,000$400,0361,904,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-24$19.82/sh20,000$396,4621,884,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-25$19.89/sh20,000$397,7441,864,739 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Shares

    2024-09-23$20.00/sh20,000$400,0361,904,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-24$19.82/sh20,000$396,4621,884,739 total(indirect: See Footnotes)
  • Sale

    Common Shares

    2024-09-25$19.89/sh20,000$397,7441,864,739 total(indirect: See Footnotes)
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by PineBridge Global Emerging Markets Partners II, L.P., a Cayman Islands limited partnership ("GEM II"), on June 14, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.83 to $20.45, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This is a joint filing by GEM II, PineBridge GEM II G.P., L.P., a Cayman Islands limited partnership ("GEM II GP"), John Leone, Kevin Clowe and Pierre Mellinger. The reported shares are held directly by GEM II. GEM II GP is the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II. Mr. Leone, Mr. Clowe and Mr. Mellinger serve on the three-member investment committee of GEM II GP, which manages the investment activities of GEM II.
  • [F4]GEM II GP, Mr. Leone, Mr. Clowe and Mr. Mellinger disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of the securities for purposes of Section 16 or any other purpose.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.595 to $20.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.85 to $19.965, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

IBEX Ltd

CIK 0001720420

Entity typeother

Related Parties

1
  • filerCIK 0001974212

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 6:45 PM ET
Size
16.4 KB